2007 Presentations

Wednesday, February 21, 2007

"Quantitative Studies of Cytomegalovirus"
Speaker: Paul Griffiths, MD

Thursday, February 22, 2007

Speaker: Richard Whitley, MD

"This year in review"
Speaker:  Walla Dempsey

"CASG 103/104/106"
Speaker: David Kimberlin, MD

"CASG 210/211"
Speakers: John Gnann, MD and Amy Agrawal, MD

"Herpes Infections of Transplant Recipients"
Speaker: Michael Boeckh, MD


"Antiviral Drugs in Development-HHV6"
Speaker:  Earl Kern, Ph.D.


"Development of SCY-635 - a potent inhibitor of cyclophilin B"
Speaker:  Sam Hopkins, Ph.D.

"CASG 113/114"
Speaker: David Kimberlin, MD


"PI Responsibilities in FDA Audit"
Speaker: Kim Havens.

"Monkey Pox"
Speaker: Anne Rimoin, Ph.D.

"BK CASG 209"
Speaker:  Ajit Limaye, MD


"Current Status of Lipophilic Cidofovir Research"
Speaker: Wendy Painter, MD


 "Update on Maribavir"
Speaker:  Steve Villano, MD

"CASG 109/112"
Speaker:  David Kimberlin, MD


Breakout Sessions 

"New Therapies in Hepatitis B"
Speaker:  Richard Pollard, MD

"CASG 109/112 - Pediatric CMV"
Speaker: David Kimberlin, MD


"CASG 209 BK Virus"
Speakers:  John Gnann, MD and Ajit Limaye, MD

Friday, February 23, 2007

"Herpes Infection of the Brain"
Speaker: Birgit Skoldenberg, MD       

"CASG 204"
John Gnann, MD

Jim Alexander, MD, MPH

Breakout Sessions

"CASG 204 HSE"
John Gnann, MD/F.Y. Aoki, MD

 "CASG 103/104/106/114"
 David Kimberlin, MD